Galectin Therapeutics Inc (NASDAQ:GALT) currently has 25 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,247,967 | 63,419 | 2.90% | $9,520,140.00 |
| OSAIC HOLDINGS, INC. | 30 Sep, 2025 | 1,224,724 | -40,660 | -3.21% | $5,241,170.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 797,669 | -94,210 | -10.56% | $3,378,128.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 633,067 | -33,124 | -4.97% | $2,682,373.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 554,261 | 523,861 | 1,723.23% | $2,350,069.00 |
| Wealthspire Advisors, LLC | 30 Sep, 2025 | 479,518 | 0 | 0.00% | $2,030,759.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30 Sep, 2025 | 446,578 | 253,378 | 131.15% | $1,891,258.00 |
| LPL Financial LLC | 30 Sep, 2025 | 360,268 | -6,710 | -1.83% | $1,525,735.00 |
| Geneos Wealth Management Inc. | 30 Sep, 2025 | 360,175 | -63,060 | -14.90% | $1,527,142.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 30 Sep, 2025 | 294,901 | 9,487 | 3.32% | $1,249.00 |
| Vivaldi Capital Management LP | 30 Sep, 2025 | 255,752 | 83,309 | 48.31% | $1,083,110.00 |
| STATE STREET CORP | 30 Sep, 2025 | 230,340 | 29,400 | 14.63% | $975,490.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 228,335 | 19,712 | 9.45% | $966,998.00 |
| RETIREMENT GUYS FORMULA LLC | 30 Sep, 2025 | 165,993 | 6,400 | 4.01% | $702,980.00 |
| Sovran Advisors, LLC | 30 Sep, 2025 | 157,405 | -31,567 | -16.70% | $798,043.00 |
| Cambridge Investment Research Advisors, Inc. | 30 Sep, 2025 | 121,204 | -111 | -0.09% | $513.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 121,065 | 324 | 0.27% | $512,710.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 110,422 | -34,106 | -23.60% | $467,637.00 |
| GROUP ONE TRADING LLC | 30 Sep, 2025 | 99,110 | 32,914 | 49.72% | $419,731.00 |
| Traynor Capital Management, Inc. | 30 Sep, 2025 | 99,100 | 1,000 | 1.02% | $419,689.00 |